S-99
| Code | Size | Price |
|---|
| SYN-1119-M100 | 100 mg | Enquire |
Quantity:
| SYN-1119-M050 | 50 mg | Enquire |
Quantity:
| SYN-1119-M001 | 1 mg | £233.00 |
Quantity:
| SYN-1119-M005 | 5 mg | £461.00 |
Quantity:
| SYN-1119-M010 | 10 mg | £719.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
S99
Appearance:
Solid.
CAS:
1124381-69-6
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS07
Hazards:
H303, H317, H333
InChi:
InChI=1S/C16H15F3N6O/c1-9(2)21-12-6-11(16(17,18)19)7-13-22-15(24-25(12)13)23-14(26)10-4-3-5-20-8-10/h3-9,21H,1-2H3,(H,23,24,26)
InChiKey:
BDAJJFZKNIYDOL-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 1124381-69-6. Formula: C16H15F3N6O. MW: 364.3. Selective ASKI inhibitor. S-99 inhibits LPS-induced TNFalpha release assay in vivo.
Molecular Formula:
C16H15F3N6O
Molecular Weight:
364.3
Package Type:
Plastic Vial
Precautions:
P261, P272, P280, P302, P352, P333, P313, P321, P363, P501
Product Description:
Selective ASKI inhibitor. S-99 inhibits LPS-induced TNFalpha release assay in vivo.
Purity:
>95%
Signal word:
Warning
Solubility Chemicals:
Soluble in DMSO or ethanol.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
Preparation of triazolopyridines as apoptosis signal-regulating kinase (ASK) inhibitors for treatment of autoimmune, inflammatory, cardiovascular, and/or neurodegenerative diseases: S. Dominique, et al.; WO2009027283 (2009)
Related Products
| Product Name | Product Code | Supplier | Selonsertib Hydrochloride | SYN-1229 | AdipoGen Life Sciences | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selonsertib | SYN-1231 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||